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The Saccharomyces cerevisiae gene SCO1 has been shown to play an essential role in copper
delivery to cytochrome c oxidase. Biochemical studies demonstrated specific transfer of copper
from Cox17p to Sco1p, and physical interactions between the Sco1p and Cox2p. Deletion of
SCO1 yeast gene results in a respiratory deficient phenotype. This study aims to gain a more
detailed insight on the effects of SCO1 deletion on S. cerevisiae metabolism. We compared,
using a proteomic approach, the protein pattern of SCO1 null mutant strain and wild-type
BY4741 strain grown on fermentable and on nonfermentable carbon sources. The analysis
showed that on nonfermentable medium, the SCO1mutant displayed a protein profile similar
to that of actively fermenting yeast cells. Indeed, on 3% glycerol, this mutant displayed an
increase of some glycolytic and fermentative enzymes such as glyceraldehyde-3-phosphate
dehydrogenase 1, enolase 2, pyruvate decarboxylase 1, and alcohol dehydrogenase 1. These data
were supported by immunoblotting and enzyme activity assay. Moreover, the ethanol assay and
the oxygen consumption measurement demonstrated a fermentative activity in SCO1 mutant
on respiratory medium. Our results suggest that on nonfermentable carbon source, the lack of
Sco1p causes a metabolic shift from respiration to fermentation.
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1 Introduction
Sco proteins (synthesis of cytochrome c oxidase [COX]) are
evolutionarily conserved; members of the Sco-protein fam-
ily have been found in eukaryotic as well as in prokaryotic
organisms [1]. Both humans and yeast have two paralogous
SCO-like genes, SCO1 and SCO2 [2], that code for mitochon-
drial metallochaperone proteins. These have an essential but
poorly understood role in copper delivery to COX. In mam-
mals, COX, the terminal enzyme of the mitochondrial respi-
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ratory chain, is present in the innermitochondrialmembrane
as a dimer with each monomer consisting of 13 subunits.
Three subunits are encoded by mitochondrial DNA (COX1,
COX2, and COX3) and the remaining ten are encoded by nu-
clear genome [3,4]. Subunits Cox1p, Cox2p, and Cox3p form
the catalytic core of the complex. The redox-active prosthetic
groups are located within Cox1p (hemes a + a3 and CuB-
center) and Cox2p (binuclear CuA-center) [5]. The assembly
of COX is a complex process that requires a large number of
ancillary nuclear factors [6]. Numerous COX assembly genes
have been identified by extensive study in yeast Saccharomyces
cerevisiae [7, 8]. Many of these have human homologues,
for example, COX10, COX11, COX15, COX17, COX19,
LRPPRC,OXA1, PET112, SCO1, SCO2, and SURF1. Perhaps
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the most thoroughly characterized aspect of COX assembly is
mitochondrial copper delivery to the nascent holoenzyme
complex and, in particular, copper delivery to the Cox2p sub-
unit’s CuA site. In eukaryotes, it has been found that pro-
teins Cox17p, Sco1p, Sco2p, and Cox11p are necessary for
copper insertion into CuA and CuB redox centers of Cox2p
[6]. The first accessory factor to be identified in this path-
way was yeast Cox17p, a small molecular weight protein that
is located both in the cytoplasm and in the intermembrane
space [9]. A high copy suppressor screen of yeast COX17 null
strain allowed the identification of yeast SCO1 and SCO2,
which show an identity of about 50% [10]. Further biochemi-
cal studies of yeast proteins demonstrated a specific transfer
of copper from Cox17p to Sco1p [11] and physical interac-
tions between both Sco proteins and Cox2p [12, 13]. More-
over, Sco2p is able to restore respiration in COX17 null mu-
tants, but not in SCO1mutants. Although these data suggest
that both Sco proteins act downstream of Cox17p in copper
delivery of COX [10], only the deletion of yeast SCO1 gene re-
sults in a respiratory deficient phenotype. In line with these
phenotypic observations, we recently reported the analysis of
mitochondrial proteome patterns in yeast deletion mutants
SCO1 and SCO2which revealed that only lack of SCO1 affects
mitochondrial function and stability. We demonstrated that
during growth on respiratory media, BY4741sco1- yeast mu-
tant cells exhibit a loss of mitochondrial membrane potential,
a decrease in the number of functional mitochondria and a
decrease in the expression level of manymitochondrial respi-
ratory function proteins in comparison to wild-type BY4741
and BY4741sco2-mutant strains. On the contrary, the SCO2
nullmutant strain showed amitochondrial proteomic pattern
similar to that of the wild-type strain [14]. At present, the role
of Sco2p in yeast mitochondrial copper delivery to COX re-
mains enigmatic. Unlike yeast cells, human cells require two
functional Sco proteins to assure viability [15]. Mutations in
either human SCO1 or SCO2 lead to severe, tissue-specific
COX deficiencies owed to a failure in holoenzyme assem-
bling. Despite their high degree of identity at the amino
acid level (40%) [11], SCO1 mutations are predominantly as-
sociated with fatal infantile hepatoencephalomyopathy [16],
whereas mutations in SCO2 result in fatal infantile cardioen-
cephalomyopathy [17, 18]. Studies on immortalized fibrob-
lasts from SCO1 and SCO2 patients suggest that Sco1p and
Sco2p have essential, nonoverlapping but cooperative func-
tions in the biogenesis of the CuA site [15,19]. Yeast SCO1 is
equivalent to mammalian SCO1. Neither human Sco1p nor
Sco2p is able to rescue the respiratory deficient phenotype
of yeast SCO1 null mutant. However, a chimera containing
the N-terminal portion of yeast Sco1p fused to the C-terminal
segment of human Sco1p is functional in yeast SCO1 null
mutant [19]. Although significant progress has been made
in the characterization of Sco proteins, particularly in yeast,
our current understanding of their exact role in COX assem-
bly remains limited. In particular, it is not known why two
closely related proteins are essential for mitochondrial func-
tion in humans but not in yeast, and howmutations in one or
the other human gene lead to different tissue-specific COX
deficiencies associated with different clinical phenotypes.
The present study aims to gain more detailed insight on
the effects of SCO1 deletion and thus of COX deficiency on S.
cerevisiae metabolism. The fact that respiration is not essen-
tial for yeast viability makes this organism an excellent model
system for delineating the molecular mechanisms underly-
ing COX assembly defects. In this regard, we analyzed the
SCO1 null mutant protein pattern comparing it to that of the
wild-type strain during growth on both fermentable and non-
fermentable carbon sources. By using two-dimensional gel
electrophoresis (2-DE) and mass spectrometry, we found an
increase in fermentative enzyme levels in SCO1 null mutant
strain on nonfermentable carbon source compared to wild-
type strain. These findings were confirmed by both Western
blot analysis and enzyme activity assay. Moreover, on respi-
ratory growth conditions, SCO1 null mutant cells displayed
an ethanol productivity and oxygen consumption similar to
that of fermentative yeast strains. These data suggest that, on
nonfermentable carbon sources, yeast cells respond to Sco1p
loss by reconfiguring their metabolism (from respiration to
fermentation) probably to overcome the absence of a func-
tional mitochondrial respiratory chain and to maintain ATP
supplies.
2 Materials and methods
2.1 Yeast strains, media, and growth conditions
The S. cerevisiae strains used in this study were as fol-
lows: wild-type BY4741 (MATa; his31; leu20; met150;
ura30, from Euroscarf) and BY4741sco1- (MATa; his31;
leu20; met150; ura30; YBR037c::kanMX4, from Eu-
roscarf). Cells were cultured at 30C in synthetic complete
(SC) medium containing 0.67% (w/v) of yeast nitrogen base
without amino acids (USbiological, USA) supplemented with
complete amino acid dropout solution (USbiological, USA).
Carbon sources were as follows: 2% (w/v) glucose (SCD); 3%
(v/v) glycerol supplemented with 0.1% (w/v) glucose (SCG);
0.1% (w/v) glucose; 3% (v/v) glycerol.
2.2 Growth phenotypes
Yeast cells were picked from fresh colonies and grown at
30C, to an optical density (OD600 nm) of 1–2 in SC medium
containing 2% glucose as carbon source. Cells were collected
by centrifugation, washed with sterile water, and then diluted
to 106 cells/mL in SCD, in SCG, SC with 0.1% glucose or
in SC with 3% glycerol fresh media, using flasks with a vol-
ume/medium ratio of 3:1. The growth curve was monitored
for 24 h by measuring the turbidity of the culture at 600 nm
(OD600nm) with a spectrophotometer.
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2.3 Sample preparation and 2DE
Yeast cells were picked, centrifuged, and washed as described
above, but diluted to 104 cells/mL in SCD and to 105 cells/mL
in SCG fresh media. To evaluate biological variation, five in-
dependent growth experiments were performed for wild-type
BY4741 and BY4741sco1- strains on SCD and on SCG me-
dia. Fifty OD600nm of cells were collected by centrifugation at
mid-logarithmic phase (after 24 h), washed twice with sterile
water, and resuspended in 1 mL of RIPA lysis buffer (50 mM
Tris-HCl, pH7.5, 150mMNaCl, 1% (v/v)Nonidet P-40, 2mM
EGTA, and 100 mMNaF) plus yeast protease inhibitors cock-
tail (Sigma Aldrich, St. Gallen, CH). Cells were broken with
glass beads in a Fastprep instrument (Savant) and protein ex-
tracts were clarified by centrifugation at 8000 × g for 10 min.
Proteins were precipitated by adding five volumes of cold ace-
tone (–20C). After 2 h at –20C, precipitates were recovered
by centrifugation at 12 000 × g for 15 min, supernatants were
discarded and pellets were washed once with cold acetone,
dried in vacuum for 5 min, dissolved in a 2D-PAGE lysis
buffer (8 M urea, 65 mM DTE, and 4% (w/v) CHAPS) and
then centrifuged at 12 000× g for 1min at room temperature.
The yeast extract samples obtained were separated by 2DE as
previously described [20,21]. Isoelectric focusing was carried
out on nonlinear wide-range immobilized pH gradients
(IPGs; pH 3.0–10; 18-cm-long IPG strips; GE Healthcare,
Uppsala, Sweden) and achieved using an Ettan IPGphorTM
system (GE Healthcare). The sample load for analytical runs
was 60 g of total protein directly on 350 L of lysis buffer
and 0.2% carrier ampholyte. For MS-preparative gels analy-
sis, 800 g of total protein was loaded on both cathodic and
anodic ends of the IPGphor Cup Loading Strip Holders (GE
Healthcare). Runs were performed at 16C, until a total of
80 000 V/h for analytical and 110 000 V/h for preparative gels
were reached. Focused strips were equilibrated in 6 M urea,
2% (w/v) SDS, 2% (w/v) DTE, 30% (v/v) glycerol, and 0.05 M
Tris-HCL pH 6.8 for 12 min and subsequently for 5 min in
the same urea/SDS/Tris-HCl buffer solution where DTT was
substituted with 2.5% iodoacetamide. The second dimension
gels were carried out at 15C on 9−16% polyacryamide
linear gradient gels (24 cm × 20 cm × 1.5 mm) at 17 W/gel
constant Watt using an Ettan Dalt II system (GEHealthcare).
Runs were performed until the dye front reached the bottom
of the gel, in accordance with Hochstrasser et al. [22]. For
analytical purposes, gels were stained with ammoniacal
silver nitrate [23]. The exposure time for silver staining was
optimized to avoid overexposure of some gels in comparison
to others. MS-preparative gels were stained with SYPRO
Ruby (Bio-rad headquarters, Hercules, CA, USA) according
to the manufacturer’s instructions.
2.4 Image analysis and statistics
Analytical gel images stained by silver nitrate were digitized
using aMolecularDynamics 300S laser densitometer (4000×
5000 pixel, 12 bits/pixel; Sunnyvale, CA, USA) while prepar-
ative gel images stained with SYPRO Ruby were digitized
with a Typhoon 9400 laser densitometer (GE Healthcare).
Two-dimensional image analysis was carried out using Im-
ageMaster 2DPlatinumsoftware version 6.0 (GEHealthcare).
Relative spot volumes calculated as %V (V single spot/V total
spots on a gel, where V is the integration of the OD over the
spot area) were used for quantitative analyses in order to de-
crease experimental errors. The normalized spot volume was
averaged and standard deviation was calculated. The analysis
was performed comparing each gel obtained from one yeast
strain (wild-type or sco1- mutant) in one growth condition
(SCD or SCG) with the other gels. Statistical analysis of pro-
tein spot variation was carried out with the two-tailed t-test of
the Excel 2007 Microsoft Office software. Protein spot varia-
tion was considered significant if it showed a p-value <0.05
and at least a twofold change in relative volume %V. We as-
sessed the false discovery rate (FDR) by the free software R
(http://www.r-project.org).
2.5 Mass spectrometry protein identification
Protein identification wasmainly carried out by peptide mass
fingerprinting (PMF) on Ettan MALDI-TOF Pro mass spec-
trometer (GE Healthcare) as previously described [24, 25].
The SYPRO Ruby stained gels were subjected to an auto-
matic cutting by Ettan Spot Picker (GEHealthcare), destained
in 2.5 mM ammonium bicarbonate and 50% ACN and
finally dehydrated in ACN. They were then rehydratated
in trypsin solution and in-gel protein digestion was per-
formed by overnight incubation at 37C. Each protein digest
(0.75 L) was spotted onto the MALDI target and allowed to
air dry. Then 0.75 L of matrix solution (saturated solution
of CHCA in 50% (v/v) ACN and 0.5% (v/v) TFA) was ap-
plied to the sample which was then dried again. Mass spectra
were acquired automatically using the Ettan MALDI Evalu-
ation software (GE Healthcare). Spectra were internally cali-
brated using the autoproteolysis peptides of trypsin (842.51
and 2211.10 Da). PMF searching was carried out in NCBInr
and Swiss Prot databases using MASCOT (Matrix Science
Ltd., London, UK, http://www.matrixscience.com). Taxon-
omy was limited to S. cerevisiae, a mass tolerance of 100 ppm
was allowed and the number of acceptedmissed cleavage sites
was set to one. Alkylation of cysteine by carbamidomethy-
lation was considered a fixed modification, while oxidation
of methionine was considered as a possible modification.
The criteria used to accept identifications included the ex-
tent of sequence coverage, the number of matched peptides,
and a probabilistic score. Tryptic digests that did not pro-
duce MALDI-TOF unambiguous identifications were subse-
quently subjected to peptide sequencing on a nanoscale LC-
ESI/MS-MS, as described in detail by Meiring et al. [26]. All
the analyses were carried out on an LC-MS system consisting
of a PHOENIX 40 (ThermoQuest Hemel Hempstead, UK)
and an LCQ DECA IonTrap mass spectrometer (Finnigan,
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SanJose, CA, USA). The peptides, after a manual injection (5
L) in a six-port valve, were trapped in a C18 trapping col-
umn (20 mm × 100 m ID × 360 mOD, Nanoseparations,
Nieuwkoop, the Netherlands) using a 100% solvent A (HPLC
grade water + 0.1% (v/v) formic acid) under a flow rate of
5 L/min for 10 min. A linear gradient up to 60% solvent
B (ACN + 0.1% (v/v) formic acid) for 30 min was used for
analytical separation and, using a precolumn splitter restric-
tor, we obtained a column flow rate of 100–125 nL/min on a
C18 analytical column (30 cm × 50 m ID × 360 m OD,
Nanoseparations). Before the injection of the next sample,
both the trapping and analytical column were equilibrated
for 10 min in 100% solvent B and for 10 min in 100% solvent
A. The ESI emitter, a gold-coated fused silica (5 cm × 25 m
ID × 360 m OD, Nanoseparations) was heated to 195C. A
high voltage of 2 kV was applied for stable spray operation.
The LC pump, the mass spectrometer as well as the auto-
matic mass spectra acquisitions were controlled using the
Xcaliburtm 1.2 system software (Thermo). The MS/MS ions
search was carried out in Swiss-Prot and NCBInr databases
using MASCOT. Taxonomy was limited to S. cerevisiae, pep-
tide precursor charge was set to 2+ or 3+, mass tolerance
of ±1.2 Da for precursor peptide and ±0.6 Da for fragment
peptides was allowed, and the number of accepted missed
cleavage sites was set to one. Alkylation of cysteine by car-
bamidomethylation was taken as a fixed modification, while
oxidation and phosphorilation were considered as possible
modifications. We consider significant peptides with individ-
ual ions scores (−10 × Log[P], where P is the probability that
the observed match is a random event) that indicate identity
(p <0.05).
2.6 Cluster analysis
Cluster analysis was carried out using the EPCLUST tool
for clustering and analysis of gene-expression data within
Expression Profiler. This set of tools for microarray anal-
ysis was developed at the European Bioinformatics Insti-
tute (EBI) [27] and is available online (http://www.bioinf.
ebc.ee/EP/EP/EPCLUST/). The data were clustered and visu-
alized as linear correlation-based distance (Pearson, centered)
and complete linkage (maximum distance).
2.7 Western blot analysis
Yeast cell growth conditions were the same as those of the
2DE experiments. Cells were lysed in ice-cold RIPA buffer
plus protease inhibitors cocktail for yeast cells (Sigma). Sam-
ples (30 g) were separated by 12% SDS-PAGE and trans-
ferred onto PVDF membrane (Millipore). Western immuno-
blottings were performed by using: a monoclonal antibody
(16G9) against yeast mitochondrial porin 1 (A-6449, Molec-
ular Probes); a monoclonal antibody (22C5) against yeast cy-
tosolic 3-phosphoglycerate kinase, PGK1 (A-6457, Molecular
Probes); rabbit polyclonal GAPDH-HRP conjugated antibod-
ies (Abcam, Cambridge, UK) against yeast GAPDH. All an-
tibodies were diluted 10 000-fold. The reaction was detected
by chemioluminescence with an ECL kit (GE Healthcare).
As loading control anti-actin antibodies (Santa Cruz, Heidel-
berg, Germany) were used. Western blot analysis was per-
formed in triplicate and two-tailed nonpaired Student’s t-test
was calculated using ORIGIN 6.0 (Microcal Software, Inc.) to
determine if the relative change in sco1- mutant strain was
statistically significant in comparison to the wt-BY4741 strain
(p <0.05).
2.8 Enzyme activity measurements
Yeast cell growth conditions were the same as those of the
2DE experiments. Cells were washed twice with sterile water
and lysed in 1 mL of TEA buffer (100 mM Triethanolamine
pH 7.6, 1 mMDTE) plus protease inhibitors cocktail for yeast
cells (Sigma). Isocitrate lyase activity was determined by the
method of Dixon and Kornberg as described by Giachetti
et al. [28]. The assay mixture contained in 1 mL final vol-
ume consisted of 80 mM HEPES (pH 7.0), 6 mM MgCl2,
4 mM phenylhydrazine. The reaction was started by adding
substrate (4 mM D,L-isocitrate). Glyoxylate-phenylhydrazone
(ε = 17 mM −1 cm −1) formation was followed at 30C at
324 nm, using a UV-2100 spectrophotometer (Shimadzu,
Columbia, MD, USA). Enolase activity was determined ac-
cording to Bergmeyer [29], following the NADH oxidation
at 340 nm, using a UV-2100 spectrophotometer (Shimadzu).
The assay mixture contained in 1 mL final volume consisted
of 80 mM triethanolamine (pH 7.6), 4 mM MgSO4, 0.2 mM
NADH, 2 mM ADP, 7 units pyruvate kinase, 10 units lactic
dehydrogenase. The reaction was started by adding substrate
(2 mM 2-phosphoglycerate). Two independent experiments
were performed. A two-tailed nonpaired Student’s t-test was
performed using ORIGIN 6.0 (Microcal Software).
2.9 Analytical determination
For the ethanol, glycerol, and glucose assay, cells were
cultured as described in the Section 2.2. Concern-
ing the ethanol production and oxygen consumption, 1
mL of growth was harvested both at mid-exponential
phase and after 24 h. The cleared supernatant was col-
lected to estimate ethanol production using the alcohol-
dehydrogenase/aldehyde-dehydrogenase method (EnzyPlus,
Diffchamb, Italy). Cells pellet was washed twice with cold wa-
ter and suspended in respiration buffer (0.1 M K-Phthalate,
pH 5.0) to an OD600 of 1.7. Oxygen consumption was mea-
sured at 30C using an oxygen electrode (Hansatech Instru-
ments). Respiratory rates are expressed as nmol O2 min−1 per
mg of cells (dry weight). Glycerol and glucose concentrations
in the medium supernatant were determined every 2 h for 24
h using enzymatic combination kits (K-GCROL andK-GLUC,
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Figure 1. Growth curve of wt-BY4741 and
BY4741 sco1- mutant strain on 2% glucose
(SCD) (A), on 3% glycerol (B), on 3% glycerol
plus 0.1% glucose (SCG) (C), and on 0.1% glu-
cose (D). Symbols: BY4741 wild-type strain;
 BY4741 sco1- mutant strain. Data repre-
sent mean and standard deviation obtained
from three independent experiments.
fromMeganzyme, Wicklow, Ireland). Experiments were per-
formed in triplicate. A two-tailed nonpaired Student’s t-test
was performed using ORIGIN 6.0 (Microcal Software).
2.10 Miscellaneous
Protein concentration was determined by standard Bradford
method (Biorad).
3 Results
3.1 Growth phenotypes
Previous reports have shown that SCO1 gene deletion af-
fects yeast growth on respiratory carbon sources such as
glycerol and ethanol. This growth defect is not detectable
on fermentable media [10, 14, 30]. On medium containing
2% glucose (SCD), sco1- mutant grew at a rate which was
indistinguishable from that of the wild-type strain wt-BY4741
(Fig. 1A). Unlike the wild-type strain, sco1- mutant was not
able to grow on medium containing only 3% glycerol as car-
bon source (Fig. 1B). On the contrary, on 3% glycerol sup-
plemented with 0.1% glucose (SCG), sco1- mutant showed
a decreased growth rate. In this condition, the sco1-mutant
strain duplicated only once in 24 h afterwhich growth stopped
(Fig. 1C). The SCG medium (5.5 mM of glucose concen-
tration) is considered as nonfermentable since the amount
of glucose required to switch metabolism from respiration
to fermentation must be above 20 mM (approximately 0.4%
(w/v)) [31,32]. Onmediumcontaining 0.1%glucose as carbon
source, sco1- mutant strain displayed a growth rate similar
to that on SCG (Fig. 1D).
3.2 Proteomic analysis
In order to investigate differences between total protein ex-
pression in S. cerevisiae BY4741 wild-type strain and in sco1-
during mid-exponential growth on glucose or glycerol as car-
bon source, we performed a proteomic analysis by 2DE. In
Fig. 2, representative 2DE images of soluble yeast proteins
from wt-BY4741 (panel A) and sco1- (panel B) grown on
SCG, and from wt-BY4741 (panel C) and sco1- (panel D)
grown on SCD are reported. Approximately 1800 spots were
detected in each silver-stained 2DE gel, representing a large
subset of the high-abundant proteins in yeast. Spots ranged
from 10 to 200 kDa and had a pH between 3 and 10. The gels
showed a relatively similar protein pattern indicating the high
degree of experimental reproducibility. The pattern and in-
tensity of the spots present in all technical replicates proved a
good overlapping to a 2DE reference gel for soluble yeast pro-
teins available at http://www.expasy.ch/swiss-2dpage/viewer.
The analysiswas performed comparing eachwild-type or sco1-
 mutant proteomic profile both on SCD and on SCG. The
results of these comparisons gave a total of 92 differentially
expressed protein spots and 68 were identified by MS. The
results of theMS identification as well as the relative amounts
of these proteins are summarized in Table 1. To provide an
overall reproducibility assessment of the proteomic analy-
sis, we estimated the FDR. The results showed that an FDR
≤ 5% is associated to the differentially expressed protein spots
(Supporting Information Table S1).
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Figure 2. Representative 2D silver-stained
gels of total protein extract from wt-BY4741
(A) and sco1- mutant strain (B) grown in
SCG, and from wt-BY4741 (C), and sco1-
 (D) grown in SCD. Black and white
circles with numbers visualize quantitative
and qualitative differences found among the
electropherograms.
3.3 Cluster analysis and identification of
differentially expressed proteins
To investigate how the two different types of carbon sources
affect the expression levels of specific proteins in wt-BY4741
and sco1-, we decided to perform a cluster analysis to high-
light proteins with similar expression patterns. The cluster-
ization allowed us to classify the 92 variations in different
clusters of proteins whose expression level followed the same
trend. Five major clusters were obtained (Fig. 3). In Table 1,
the cluster subdivision of the 68 proteins identified by MS as
well as their relative amounts and biological functions were
reported.
3.3.1 Cluster 1
It includes a total of 16 protein spots whose expression level
increased in wt-BY4741, in sco1- strains grown on SCD
and in sco1- strain grown on SCG. Among them, 14 were
identified by MS. As shown in Table 1, we identified some
glycolytic enzymes such as enolase 2 (Spots 2, 5, 10, and
12), 3-phosphoglycerate kinase (Spot 6), glyceraldehyde-3-
phosphate dehydrogenase 1 (GAPDH) (Spot 13). Concern-
ing fermentation, we found pyruvate decarboxylase isozyme
1 (Spot 4) and an enzyme involved in glycerol biosynthesis:
glycerol-3-phosphatase 1 (Spot 3). We also identified a group
of stress response proteins: heat shock protein Hsp60p (Spot
1), peroxiredoxin type-2 (Spots 7, 11, and 15), and thioredoxin
reductase 1 (Spot 8). Finally, we identified carboxypeptidase
Y inhibitor (Spot 9).
3.3.2 Cluster 2
It includes a total of 21 protein spots whose expression is
correlated with the carbon source and not with SCO1 gene
deletion.During growth onSCD, these proteins resulted over-
expressed in both strains in comparison to growth on SCG.
Twelve proteinswere successfully identified byMS. As shown
in Table 1, these proteins belong to glycolytic and fermenta-
tive pathways such as enolase 2 (Spot 22), glyceraldehyde-3-
phosphate dehydrogenase (Spot 26), and pyruvate decarboxy-
lase isozyme 1 (Spot 29). We found a protein involved in
the pentose phosphate pathway, 6-phosphogluconolactonase
(Spot 31), and an enzyme belonging to the uracil biosynthesis
pathway: orotate phosphoribosyltransferase 1 (Spot 37). We
also identified a group of stress response proteins such as
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Figure 3. Cluster analysis of differentially expressed proteins in wild-type and sco1- mutant strains during growth in SCD and SCG.
(Right) Normalized %Vmean values of differences obtained by %V values individually computed in the yeast strains wt-BY4741 and sco1-
mutant. Each reported value is proportional to the intensity of the color and its corresponding spot number is annotated on the right of
the diagram near the complete linkage clustering based on Pearson distance. The major clusters are numbered from top to bottom. (Left)
Normalized %V mean values of the four tested conditions clustered in five main groups. Cluster number and size are reported. The color
saturation indicates the magnitude of relative spot level (black = 0 and red = 100).
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
1776 T. Gamberi et al. Proteomics 2012, 12, 1767–1780
peroxiredoxin type-2 (Spot 24) and peroxiredoxin 1 (Spot 36),
thioredoxin-2 (Spot 34), and cytosolic superoxide dismutase
(Spots 21 and 25). Finally, we identified two protein spots as-
sociated with ribosome assembly: 40S ribosomal protein S6
(Spot 19) and 60S ribosome maturation factor (Spot 20).
3.3.3 Cluster 3
It includes 12 protein spots that have the common trend
to increase their expression level only when sco1- strain is
grown on SCG. We identified ten proteins by MS (Table 1).
Three of them correspond to alcohol dehydrogenase 1 (Spots
40, 41, and 49). We identified the glycolytic enzyme glucose-
6-phosphate isomerase (Spot 47) and three proteins involved
in amino acidmetabolism: ketol-acid reductoisomerase (Spot
45), cystationine gamma-lyase (Spot 48), and dihydroorotate
dehydrogenase (Spot 42). Finally, we identified Asc1p, the
G-protein beta subunit of Gpa2p (Spot 44).
3.3.4 Cluster 4
It includes 17 proteins showing an opposite expression trend
in comparison to the Cluster 2. These proteins resulted up-
regulated in both wt-BY4741 and in sco1- strains grown
on SCG. Twelve proteins have been successfully identi-
fied (Table 1). Most of these proteins are involved in en-
ergy and carbohydrate metabolism: hexokinase isoenzyme 1
(Spot 53, 58, and 66), the glucose-repressible alcohol dehy-
drogenase 2 (Spot 59), and the mitochondrial aldehyde dehy-
drogenase 4 (Spot 60). We also identified the D-lactate dehy-
drogenase (Spot 56).
3.3.5 Cluster 5
It is a group of 28 protein spots showing an opposite trend
in comparison to that of Cluster 1. The expression level of
these protein spots increased in wt-BY4741 strain on SCG.
We identified 20 proteins by MS. Most of these are mito-
chondrial proteins involved in the respiratory chain, for ex-
ample, two subunits of COX: subunit 4 (Spot 72) and subunit
6 (Spot 78) and the ATP synthase complex (Spots 80, 83,
87, and 90), while others are involved in the citric acid cy-
cle (TCA) and in metabolite and protein import across the
mitochondrial membrane. TCA cycle enzymes include: the
beta subunit of succinyl-CoA ligase (Spot 76); the mitochon-
drial malate dehydrogenase (Spot 77), and the mitocondrial
dihydrolipoyl transsuccinylase (Spots 79 and 91) component
of the 2-oxoglutarate dehydrogenase complex. We also identi-
fied a key enzyme of the glyoxylate cycle: isocitrate lyase (Spot
81). We identified two enzymes involved in gluconeogenesis:
enolase 1 (Spot 74) and Triose phosphate isomerase (Spot 84).
Finally, we identified themitochondrial outermembrane pro-
tein porin 1 (Spot 68) and a group of proteins of the stress
response pathway: glutaredoxin (Spot 70) and the mitochon-
drial peroxiredoxin (Spot 88).
3.4 Validation of proteomic results
In order to validate proteomic results, the amount ofGAPDH,
3-phosphoglycerate kinase (Pgk1p), and porin 1 (Por1p) was
evaluated by Western blot analysis (Fig. 4A). In line with
the proteomic results (Fig. 4B), the amount of GAPDH and
Pgk1p in the sco1- yeast strain on SCG was similar to that
of sco1- yeast and wt-BY4741 on SCD. In fact, in sco1-
yeast on SCG, the GAPDH amount was 2.7-fold higher and
the Pgk1p amount was 1.8-fold higher than in wt-BY4741 on
SCG. Moreover, on SCG, this mutant displayed a decrease
of the Por1p level compared to both the wild type on SCG
(fourfold lower) and to sco1- yeast and wt-BY4741 on SCD
(threefold and 3.8-fold, respectively).
Furthermore, the enzyme activity of enolase 2 and isoci-
trate lyase was assayed (Fig. 5). On SCG, the increase of eno-
lase expression level found in sco1-mutant is associatedwith
a twofold increased enzyme activity compared to wt-BY4741
on SCG. Concerning the isocitrate lyase, on SCG, sco1- cells
displayed an enzyme activity similar to that of wt-BY4741 and
sco1- cells on SCD while it resulted 28-fold lower compared
to the wt-BY4741 strain on SCG in agreement with the 2-DE
results.
Theproteomic data pointed out that onSCG, sco1-mutant
strain displayed an increase in the expression level of some
fermentative enzymes such as pyruvate decarboxylase 1 and
alcohol dehydrogenase 1. To confirm these results, we as-
sayed ethanol production during bothmid-exponential phase
and after 24 h of growth on SGC. We observed a higher fer-
mentative capacity of the sco1-mutant cells compared to the
wt-BY4741 strain (Fig. 6A). The amount of ethanol production
in sco1-mutant cells duringmid-exponential growthwas 23-
fold higher than in the wt-BY4741 strain. After 24 h, this dif-
ference was more evident; with an ethanol output in mutant
strain 54 times that of control strain. These data suggested
that yeast cells reconfigure their metabolism from respira-
tion to fermentation as response to the lack of SCO1 gene.
To support this hypothesis, we also evaluated the oxygen con-
sumption in this experimental condition. On SCG, sco1-
mutant cells were nonrespiring since no oxygen consump-
tion was observed (Fig. 6B). To clarify whether the ethanol
is produced as a result of fermentation of the 0.1% glucose
present in the media or whether a part of glycerol is uti-
lized as substrate, we evaluated the glucose and glycerol con-
sumption on SCG for 24 h (Fig. 6C and D). We found that
in sco1- mutant, the glucose consumption rate was higher
than in wt-BY4741 since glucose was exhausted after 8 h
instead of 10 h observed for wild type. On the contrary, in
sco1- mutant, no glycerol consumption was detected after
24 h of growth. These experiments confirmed that sco1-mu-
tant has nonrespiring phenotype on SCG and that ethanol is
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Figure 4. (A) Representative Western blot images and relative densitometric bar graphs of GAPDH (glyceraldehyde-3-phosphate dehydro-
genase 1), phosphoglycerate kinase (Pgk1p), porin 1 (Por1p) for wt-BY4741, and sco1- yeast strains grown on SCD (closed bars) and on
SCG (open bars). Actin was used as protein loading control. Data represent mean and standard deviation obtained from three independent
experiments. (B) Representative 2-DE images and relative densitometric bar graphs of GAPDH spot (n.13), Pgk1p spot (6), and Por1p spot
(68) for wt-BY4741 and sco1- yeast strains cultured on SCD (closed bars) and SCG (open bars).
produced by fermentation of the 0.1% glucose present in the
medium.
4 Discussion
In this study, we investigated the effect of SCO1 deletion
on S. cerevisiae metabolism by comparing the proteome
of sco1- yeast strain with that of wt-BY4741 during mid-
exponential phase on both fermentable and nonfermentable
carbon sources. We used wt-BY4741 as control strain since
it has been demonstrated, using complementation tests, that
the kanMX deletion cassette was without significant effect on
sco1- phenotype [33].
The proteomic analysis pointed out differentially expressed
protein belonging to several functional categories: energy
metabolism, C-compound and carbohydrate metabolism,
oxygen and reactive oxygen species metabolism, protein and
amino acid biosynthesis, protein translocation, folding and
transport of metabolites. To present our results, we used
a cluster analysis that groups similarly responsive protein
spots. Clusters 2 and 4 include proteins whose expression
profiles depend on growth conditions instead of SCO1 dele-
tion. On the other hand, clusters 1, 3, and 5 are the most
relevant groups of differentially expressed protein spots, rep-
resenting proteins that could be affected directly or indirectly
by SCO1 gene deletion. Clusters 1, 3, and 5 show that SCO1
mutation has consequences on the proteome only during
respiratory growth condition. In fact, on SCG, the sco1-mu-
tant proteome profile displays a high degree of similarity to
that of wild type and sco1- on SCD. In particular, sco1-
mutant cells grown on SCG showed a down-regulation of
some gluconeogenic and oxidative metabolism-related pro-
teins and an increase of some glycolytic and fermentative
enzymes (cluster 1). The differences observed in the levels
of some TCA enzymes and of some COX subunits in the
sco1-mutant could reflect mitochondrial dysfunction (clus-
ter 5). This is probably connected to the role of Sco1p in COX
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Figure 5. Specific activity of eno-
lase (A) and isocitrate lyase (B)
for wt-BY4741 and sco1- mutant
strain cultured on SCD (closed bars)
and on SCG (open bars). Data rep-
resent mean and standard devia-
tion obtained from two independent
experiments.
Figure 6. Analytical determinants.
Ethanol production (A) and oxy-
gen consumption (B) in wt-BY4741
(closed bars) and sco1-mutant strain
(open bars) on SCG medium at mid-
exponential phase and after 24 h
of growth. Glucose (C) and glycerol
(D) consumption in wt-BY4741 ()
and sco1- mutant strain () on SCG
medium for 24 h. Data representmean
and standard deviation obtained from
three independent experiments.
assembly and hence in respiratory chain activity. Moreover,
the reduced level of several subunits of theATP synthase com-
plex could justify growth defects on nonfermentable carbon
sources. Deletion of ATP genes leads to a “petite” pheno-
type that is slow-growing and unable to survive on nonfer-
mentable carbon sources [34]. In cluster 3, which includes
protein spots over-expressed in sco1- on SCG, we found
Asc1p, ortholog of the mammalian protein RACK1, which
has broad array of functions. Yeast Asc1p and RACK1 are
core 40S ribosomal proteins and are implicated in transla-
tional control [35]. Moreover, Asc1p functions as G-protein
beta subunit of Gpa2p involved in the Ras2/cAMP pathway.
In this regard, the increase of Asc1p expression level could
be linked to the ATP synthase defect observed in the sco1-
mutant strain grown on glycerol. This hypothesis is based
on a previous study that has shown an unusual relationship
between Ras growth-regulatory pathway and mitochondrial
energy transduction. In particular, T. Mubachi [36] demon-
strated that RAS2/ASC1 expression suppresses the growth
defect caused by ATP1–2 mutation. The proteomic results
pointed out that the lack of SCO1 leads to mitochondrial
dysfunction and to an increase of some glycolytic and fer-
mentative enzymes. These findings imply that sco1-mutant
cells to overcome the absence of a functional mitochondrial
respiratory chain and to maintain ATP supplies may adapt
their metabolism by repressing the expression of genes in-
volved in the respiratory metabolism and conversely activat-
ing fermentative genes, regardless of the carbon source. In
these regards, the sco1- mutant showed an increase in eno-
lase enzymatic activity and ethanol production. The ethanol
is produced as a result of fermentation of the 0.1% glucose
present in SCGmedia since we demonstrated the inability of
themutant to consume glycerol and thus to grow onmedium
containing only this carbon source. The claim that yeast cells
reconfigure their metabolism from respiration to fermenta-
tion was also supported by the fact that on SCG sco1- cells
do not consume oxygen. Since sco1- mutant is able to me-
tabolize only 0.1% glucose, despite the activation of some
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fermentative enzymes, it showed a reduced growth pheno-
type on SCG.
Our results suggest that the sco1- mutant cells displayed
on SCG a similar defective response as respiratory-deficient
petite cells. Recently, it has been shown that petite mu-
tants are defective in up-regulation of genes involved in uti-
lization of nonfermentable carbon source, suggesting the
involvement of mitochondrial function in glucose repres-
sion [37]. It should be notice that several reports have pro-
vided evidence that compromised mitochondria, such as
in respiratory-deficient petite cells, lead to a compensatory
genome response that has been termed “retrograde” response
[38–40]. This is a pathway of communication frommitochon-
dria to the nucleus whereby the expression of some nuclear
genes is altered in cells with mitochondrial dysfunction. The
main feature of this response is the activation of alternative
pathways that compensate for respiratory-deficient state [41].
Because sco1- mutant cells displayed a similar defective re-
sponse as respiratory-deficient petite cells, we hypothesized
that the loss of SCO1 gene can lead to the retrograde response
activation. These findings are in line with our previous paper
on SCO mutants [14]. In fact, we found in sco1- yeast mi-
tochondrial proteome an increase in the expression level of
Cit1p, an enzyme of the TCA cycle that is usually up-regulated
in the retrograde response.However, apart fromCit1p, we did
not find any other protein involved in the retrograde response.
Thus, the possible retrograde response activation is worthy
of further investigation.
We can conclude that in yeast cells grown on nonfer-
mentable carbon sources, the deletion of SCO1 gene seems
to cause a metabolic switch (from respiration to fermenta-
tion) to overcome the absence of a functional mitochondrial
respiratory chain and to maintain ATP supplies. Future stud-
ies should further investigate the effect of SCO1 deletion on
yeast metabolic pathways evaluating the activity of key en-
zymes during growth on fermentable and nonfermentable
carbon sources and examining how genes known to be regu-
lated by the retrograde response are regulated in wt-BY4741
and sco1-mutant cells.
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